Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies

Clinical trial NCT00856180 · COMPLETED

Trial details

NCT number: NCT00856180
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Peritoneal Cancer Fallopian Tube Cancer

Start date: 2009-02-01
Primary completion: 2010-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.